
Listen Now: Business Wars | The Race to Ozempic
Even The Royals
00:00
Novo's Two-Front Battle
David Brown frames Novo Nordisk's fight against fakes while competing with Eli Lilly in a $28 billion market race.
Play episode from 03:31
Transcript

David Brown frames Novo Nordisk's fight against fakes while competing with Eli Lilly in a $28 billion market race.